The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 10, 2018

Filed:

Feb. 01, 2016
Applicant:

Yale University, New Haven, CT (US);

Inventors:

Peter M. Rabinovich, Madison, CT (US);

Sherman M. Weissman, New Haven, CT (US);

Erkut Bahceci, Hamden, CT (US);

Marina E. Komarovskaya, Milford, CT (US);

Assignee:

Yale University, New Haven, CT (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/66 (2006.01); C12N 15/85 (2006.01); A61K 48/00 (2006.01); C12N 5/074 (2010.01); A61K 35/17 (2015.01); A61K 35/33 (2015.01); A61K 35/36 (2015.01); A61K 35/12 (2015.01);
U.S. Cl.
CPC ...
C12N 15/85 (2013.01); A61K 35/17 (2013.01); A61K 35/33 (2013.01); A61K 35/36 (2013.01); A61K 48/005 (2013.01); C12N 5/0696 (2013.01); A61K 2035/124 (2013.01); C12N 2501/602 (2013.01); C12N 2501/603 (2013.01); C12N 2501/604 (2013.01); C12N 2501/606 (2013.01); C12N 2506/094 (2013.01); C12N 2506/1307 (2013.01); C12N 2510/00 (2013.01);
Abstract

RNA prepared by in vitro transcription using a polymerase chain reaction (PCR)-generated template can be introduced into a cell to modulate cell activity. This method is useful in de-differentiating somatic cells to pluripotent, multipotent, or unipotent cells; re-differentiating stem cells into differentiated cells; or reprogramming of somatic cells to modulate cell activities such as metabolism. Cells can also be transfected with inhibitory RNAs, such as small interfering RNA (siRNA) or micro RNA (miRNA), or combinations thereof to induce reprogramming of somatic cells. For example, target cells are isolated from a donor, contacted with one or more RNA's causing the cells to be de-differentiated, re-differentiated, or reprogrammed in vitro, and administered to a patient in need thereof. The resulting cells are useful for treating one or more symptoms of a variety of diseases and disorders, for organ regeneration, and for restoration of the immune system.


Find Patent Forward Citations

Loading…